Slideshow
Author(s):
Migraine is the second leading cause of disability worldwide. New data show the number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades.
FDA Approves First Autoinjector Form of DHE for Acute Migraine and Cluster Headache
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
FDA Action Update, April 2025: Approvals, Expansion, and Authorization
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
Eric Baron, DO, on the Approval of CT-132: A Digital Shift in Migraine Care
NeurologyLive® Friday 5 — May 2, 2025